What did @coachedbyzane01 actually say?
The claim is straightforward: a client using TB-500 experienced rapid shoulder recovery but also developed intense nighttime hunger, raiding the fridge repeatedly after waking up starving. The creator explains this as a logical downstream effect, arguing that because TB-500 speeds recovery and improves blood flow and nutrient delivery, the body simply demands more energy as fuel. The advice at the end: clear the junk food from your house before starting.
To be fair, the creator is not promising miracles. They are framing this as a cautionary story, which is a more honest approach than most peptide content on this platform. The problem is that the mechanistic explanation they offer is built on assumptions that the available science does not fully support.
Does the science back this up?
Partially, but the mechanism the creator describes is speculative at best. TB-500, the synthetic analogue of the endogenous protein Thymosin Beta-4, does have documented roles in tissue repair, angiogenesis, and anti-inflammatory signaling. What it does not have is robust human clinical trial data, period.
Most of what we know about Thymosin Beta-4 comes from preclinical animal studies. Goldstein et al. (2012, Annals of the New York Academy of Sciences) reviewed the peptide's roles in wound healing and cardiac repair in animal models. Human data is essentially limited to two small cardiac trials. The idea that TB-500 meaningfully elevates metabolic demand enough to trigger binge-level nighttime hunger in humans is not supported by any published study. Increased angiogenesis does not automatically translate to a measurable caloric deficit that would wake someone up hungry at 2am. That leap is the creator's own inference, and it is not a small leap.
What did they get wrong (or right)?
They got the general biology directionally correct and got the mechanistic explanation wrong. Yes, tissue repair is metabolically expensive. That is not controversial. Protein synthesis, inflammation resolution, and cell proliferation all consume energy. But the creator's framing, that TB-500 is "speeding up recovery so quickly" that the body demands dramatic extra fuel, attributes a level of systemic metabolic impact to this peptide that has not been demonstrated in human trials.
The nighttime hunger itself could have multiple explanations having nothing to do with TB-500. Did this client change their training volume after their shoulder improved? Were they sleeping differently? Were they taking anything else? A single anecdote with no controls is not a side effect profile. Presenting it as a known but underreported side effect of TB-500 is misleading, even if the creator's intentions are good. To their credit, they did not claim TB-500 cures anything, and they did not give dosing instructions. That restraint matters.
What should you actually know?
TB-500 is not FDA-approved for human use. It is sold as a research chemical in many markets, and its compounded form exists in a regulatory gray area. The safety profile in humans is genuinely unknown because long-term human trials do not exist. Anyone telling you they have mapped out the side effect profile of TB-500 from client anecdotes is working without adequate data.
The hunger phenomenon described here is plausible but unconfirmed. If you are using a recovery-focused peptide and increasing training load simultaneously, yes, you may need more calories. That is basic exercise physiology, not a peptide-specific side effect. The practical advice, remove temptation foods from the house, is reasonable regardless of the cause. But attributing the mechanism specifically to TB-500's effect on blood flow and nutrient delivery without evidence is the kind of confident speculation that makes peptide misinformation hard to counter, because it sounds just scientific enough to be convincing.
- No published human clinical trial has documented increased hunger as a side effect of Thymosin Beta-4 or TB-500.
- Preclinical data from Goldstein et al. (2012) and Ho et al. (2016, Expert Opinion on Biological Therapy) covers tissue repair and cardiac applications, not metabolic appetite effects.
- Anyone using TB-500 should do so under physician supervision given the absence of long-term human safety data.